2024

  1. Uno M, Nakamaru Y, Yamashita F. Application of machine learning techniques in population pharmacokinetics/pharmacodynamics modeling. Drug Metab Pharmacokinet, in press.
  2. Zhu C, Takemoto H, Higuchi Y, Yamashita F. Programmed immobilization of living cells using independent click pairs. Biochem Biophys Res Commun. 699, 149556 (2024).

2023

  1. Nomura S, Sukowati EW, Shigeno Y, Takahashi M, Kato A, Benno Y, Yamashita F, Mukai H. Blautia coccoides JCM1395T Achieved Intratumoral Growth with Minimal Inflammation: Evidence for Live Bacterial Therapeutic Potential by an Optimized Sample Preparation and Colony PCR Method. Pharmaceutics. 15(3):989 (2023).
  2. Ueno R, Kuninori M, Sumi T, Sadeghian RB, Takata Y, Iguchi A, Tsuda M, Yamashita F, Ichikawa K, Yokokawa R. Relationship between Adsorption and Toxicity of Nephrotoxic Drugs in Microphysiological Systems (MPS). Micromachines (Basel). 14(4):761 (2023).

2022

  1. Ota R, Yamashita F: Application of machine learning techniques to the analysis and prediction of drug pharmacokinetics. J Control Release, 352, 961-969 (2022).
  2. Kurebayashi N, Murayama T, Ota R, Suzuki J, Kanemaru K, Kobayashi T, Ohno S, Horie M, Iino M, Yamashita F, Sakurai T. Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2. J Gen Physiol. 154(9), e202112869 (2022).
  3. Sasaki Y, Tatsuoka H, Tsuda M, So K, Higuchi Y, Takayama K, Torisawa YS, Yamashita F. Intestinal permeability of drugs in Caco-2 cells cultured in microfluidic devices, Biol Pharm Bull, 45(9), 1246-1253 (2022).
  4. Zhang Q, Taniguchi S, So K, Tsuda M, Higuchi Y, Hashida M, Yamashita F. CREB is a potential marker associated with drug-induced liver injury: identification and validation through transcriptome database analysis. J Toxicol Sci, 47(8), 337-348 (2022).
  5. Chantarasrivong C, Okada R, Yamanea Y, Yang X, Higuchi Y, Konishi M, Komura N, Ando H, Yokokawa R, Yamashita F: Disposition of E-selectin-targeting liposomes in tumor spheroids with a perfusable vascular network. Drug Metab Pharmacokin, 46, 100469 (2022).
  6. Wang M, Tsuda M, Deguchi S, Higuchi Y, So K, Torisawa YS, Takayama K, Yamashita F: Application of perfluoropolyether elastomers in microfluidic drug metabolism assays. Int J Pharm, 627, 122253 (2022).

2021

  1. Deguchi S, Tsuda M, Kosugi K, Sakamoto A, Mimura N, Negoro R, Sano E, Nobe T, Maeda K, Kusuhara H, Mizuguchi H, Yamashita F, Torisawa YS, Takayama K. Usability of polydimethylsiloxane-based microfluidic devices in pharmaceutical research using human hepatocytes. ACS Biomater Sci Eng, 7(8), 3648-3657 (2021).
  2. Ota R, So K, Tsuda M, Higuchi Y, Yamashita F. Prediction of HIV drug resistance based on the 3D protein structure: Proposal of molecular field mapping. PLoS One, 16(8), e0255693 (2021).
  3. Tanaka Y, Higashihara K, Nakazawa MA, Yamashita F, Tamada Y, Okuno Y. Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection. Sci Rep, 11(1), 11241 (2021).
  4. Sano E, Deguchi S, Matsuoka N, Tsuda M, Wang M, Kosugi K, Mori C, Yagi K, Wada A, Yamasaki S, Kawai T, Yodogawa M, Mizuguchi H, Nakazawa N, Yamashita F, Torisawa YS, Takayama K. Generation of tetrafluoroethylene-propylene elastomer-based microfluidic devices for drug toxicity and metabolism studies. ACS Omega, 6(38), 24859-24865 (2021).
  5. Haidar MK, Yamashita F, Hashida M. Minocycline hydrochloride controlled-release microsphere preparation process optimization based on the robust design method. Turk J Pharm Sci, 18(6), 752-760 (2021).

2020

  1. Nomura S, Takahashi M, Kato AH, Wada Y, Watanabe Y, Yamashita F, Mukai H. Biosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography. Int J Pharm. 590:119950 (2020).
  2. Abdalkader R, Unga J, Maruyama K, Yamashita F, Hashida M. The Application of the in-Situ Hyperthermia Emission from Acoustic Nanodroplets for Theranostic Dual-Imaging and Antitumor Modalities. Biol Pharm Bull. 43(7):1141-1145 (2020).
  3. Tanaka Y, Tamada Y, Ikeguchi M, Yamashita F, Okuno Y. System-Based Differential Gene Network Analysis for Characterizing a Sample-Specific Subnetwork. Biomolecules. 10(2):306 (2020).
  4. Taniguchi Y, Oyama N, Fumoto S, Kinoshita H, Yamashita F, Shimizu K, Hashida M, Kawakami S. Tissue suction-mediated gene transfer to the beating heart in mice. PLoS One. 15(2):e0228203 (2020).
  5. Oyama N, Takahashi H, Kawaguchi M, Miyamoto H, Nishida K, Tsurumaru M, Nakashima M, Yamashita F, Hashida M, Kawakami S. Effects of Tissue Pressure on Transgene Expression Characteristics via Renal Local Administration Routes from Ureter or Renal Artery in the Rat Kidney. Pharmaceutics. 12(2):114 (2020).

2019

  1. Abdalkader R, Unga J, Yamashita F, Maruyama K, Hashida M. Evaluation of the Theranostic Potential of Perfluorohexane-Based Acoustic Nanodroplets. Biol Pharm Bull. 42(12):2038-2044 (2019).
  2. Feng C, Zhang H, Chen J, Wang S, Xin Y, Qu Y, Zhang Q, Ji W, Yamashita F, Rui M, Xu X. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer. Int J Pharm. 560:191-204 (2019).
  3. Rahimova N, Babazada H, Higuchi Y, Yamashita F, Hashida M. Development of mKO2 fusion proteins for real-time imaging and mechanistic investigation of the degradation kinetics of human IκBα in living cells. Biochim Biophys Acta Mol Cell Res. 1866(2):190-198 (2019).
  4. Ota R, Ishii H, Tsuda M, Higuchi Y, Yamashita F. A model-based comparative meta-analysis of the efficacy of dolutegravir-based and efavirenz-based regimens in HIV-infected patients. J Infect Chemother. 25(9):687-694 (2019).
  5. Abdalkader R, Unga J, Yamashita F, Maruyama K, Hashida M. Evaluation of the Theranostic Potential of Perfluorohexane-Based Acoustic Nanodroplets. Biol Pharm Bull. 42(12):2038-2044 (2019).